H
Hong Wu
Researcher at Fox Chase Cancer Center
Publications - 58
Citations - 3396
Hong Wu is an academic researcher from Fox Chase Cancer Center. The author has contributed to research in topics: Melanoma & Senescence. The author has an hindex of 25, co-authored 58 publications receiving 2996 citations. Previous affiliations of Hong Wu include Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Lysosome-mediated processing of chromatin in senescence
Andre Ivanov,Jeff S. Pawlikowski,Indrani Manoharan,John van Tuyn,David M. Nelson,Taranjit Singh Rai,Parisha P. Shah,Graeme Hewitt,Viktor I. Korolchuk,João F. Passos,Hong Wu,Shelley L. Berger,Peter D. Adams +12 more
TL;DR: Senescent cells extrude fragments of chromatin from the nucleus into the cytoplasm, where they are processed by an autophagic/lysosomal pathway.
Journal ArticleDOI
Increased expression of stem cell markers in malignant melanoma
TL;DR: The increased expression of CD166, CD133, and nestin in melanoma suggests that progression to malignant melanoma likely involves genetic pathways instrumental to stem cell biology and normal tissue development.
Journal ArticleDOI
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Keiran S.M. Smalley,Mercedes Lioni,Maurizia Dalla Palma,Min Xiao,Brijal Desai,Suzanne Egyhazi,Johan Hansson,Hong Wu,Alastair J. King,Patricia Van Belle,David E. Elder,Keith T. Flaherty,Meenhard Herlyn,Katherine L. Nathanson +13 more
TL;DR: Increased levels of cyclin D1, resulting from genomic amplification, may contribute to the BRAF inhibitor resistance of BRAF V600E–mutated melanomas, particularly when found in the context of a CDK4 mutation/overexpression.
Journal ArticleDOI
Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutations and Immunohistochemical Expression: A Gynecologic Oncology Group Study
Russell J. Schilder,Michael W. Sill,Xiaowei Chen,Kathleen M. Darcy,Steven L. Decesare,George Lewandowski,Roger B. Lee,Cletus A. Arciero,Hong Wu,Andrew K. Godwin +9 more
TL;DR: Gefitinib was well tolerated but had minimal activity in unscreened patients with recurrent ovarian or primary peritoneal carcinoma, and activating mutations in catalytic domain of EGFR in 3.5% of ovarian cancers is the first to document.
Journal ArticleDOI
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
Katherine M. Aird,Gao Zhang,Hua Li,Zhigang Tu,Benjamin G. Bitler,Azat Garipov,Hong Wu,Zhi Wei,Stephan N. Wagner,Stephan N. Wagner,Meenhard Herlyn,Rugang Zhang +11 more
TL;DR: It is shown that a decrease in deoxyribonucleotide triphosphate (dNTP) levels underlies oncogene-induced stable senescence-associated cell growth arrest, and suppression of nucleotide metabolism by RRM2 repression is also necessary for maintenance of the stable sen Escherichia-associatedcell growth arrest.